Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers
Authors:
- 13 April 2022
- journal article
- research article
- Published by Elsevier in Cell Host & Microbe
- Vol. 30 (4) , 583-598.e8
Abstract
No abstract availableKeywords
Funding Information
- Liventa Bioscience (4500002475)
- Wellcome Trust
- Biomedical Advanced Research and Development Authority
This publication has 109 references indexed in Scilit:
- CD-HIT: accelerated for clustering the next-generation sequencing dataBioinformatics, 2012
- Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Treating Clostridium difficile Infection With Fecal Microbiota TransplantationClinical Gastroenterology and Hepatology, 2011
- Cefoperazone-treated mice as an experimental platform to assess differential virulence ofClostridium difficilestrainsGut Microbes, 2011
- Predicting a Human Gut Microbiota’s Response to Diet in Gnotobiotic MiceScience, 2011
- Biopython: freely available Python tools for computational molecular biology and bioinformaticsBioinformatics, 2009
- Bile Salts and Glycine as Cogerminants for Clostridium difficile SporesJournal of Bacteriology, 2008
- Ruminococcin A, a New Lantibiotic Produced by a Ruminococcus gnavu s Strain Isolated from Human FecesApplied and Environmental Microbiology, 2001
- Basic local alignment search toolJournal of Molecular Biology, 1990